Phocas Financial Corp’s Chembio diagnostics, Inc. CEMI Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q4 | – | Sell |
-10,000
| Closed | -$4K | – | 335 |
|
|
2022
Q3 | $4K | Hold |
10,000
| – | – | ﹤0.01% | 201 |
|
|
2022
Q2 | $7K | Hold |
10,000
| – | – | ﹤0.01% | 201 |
|
|
2022
Q1 | $8K | Sell |
10,000
-20,000
| -67% | -$18.7K | ﹤0.01% | 209 |
|
|
2021
Q4 | $34K | Hold |
30,000
| – | – | ﹤0.01% | 193 |
|
|
2021
Q3 | $75K | Hold |
30,000
| – | – | 0.01% | 206 |
|
|
2021
Q2 | $89K | Hold |
30,000
| – | – | 0.01% | 214 |
|
|
2021
Q1 | $105K | Buy |
30,000
+10,000
| +50% | +$55.7K | 0.01% | 199 |
|
|
2020
Q4 | $95K | Buy |
+20,000
| New | +$103K | 0.01% | 191 |
|
|
2020
Q3 | – | Sell |
-20,000
| Closed | -$94.7K | – | 187 |
|
|
2020
Q2 | $65K | Hold |
20,000
| – | – | 0.01% | 192 |
|
|
2020
Q1 | $102K | Buy |
+20,000
| New | +$80.9K | 0.02% | 184 |
|
|
2019
Q4 | – | Sell |
-20,000
| Closed | -$97.5K | – | 194 |
|
|
2019
Q3 | $122K | Hold |
20,000
| – | – | 0.01% | 193 |
|
|
2019
Q2 | $122K | Hold |
20,000
| – | – | 0.01% | 210 |
|
|
2019
Q1 | $111K | Hold |
20,000
| – | – | 0.01% | 192 |
|
|
2018
Q4 | $113K | Hold |
20,000
| – | – | 0.01% | 219 |
|
|
2018
Q3 | $210K | Hold |
20,000
| – | – | 0.02% | 212 |
|
|
2018
Q2 | $222K | Hold |
20,000
| – | – | 0.02% | 214 |
|
|
2018
Q1 | $160K | Hold |
20,000
| – | – | 0.01% | 215 |
|
|
2017
Q4 | $164K | Hold |
20,000
| – | – | 0.01% | 208 |
|
|
2017
Q3 | $0 | Hold |
20,000
| – | – | ﹤0.01% | 215 |
|
|
2017
Q2 | $121K | Hold |
20,000
| – | – | 0.01% | 201 |
|
|
2017
Q1 | $106K | Hold |
20,000
| – | – | 0.01% | 228 |
|
|
2016
Q4 | $136K | Sell |
20,000
-1,200
| -6% | -$8.31K | 0.01% | 225 |
|
|
2016
Q3 | $157K | Hold |
21,200
| – | – | 0.01% | 245 |
|
|
2016
Q2 | $174K | Hold |
21,200
| – | – | 0.01% | 244 |
|
|
2016
Q1 | $127K | Hold |
21,200
| – | – | 0.01% | 243 |
|
|
2015
Q4 | $113K | Hold |
21,200
| – | – | 0.01% | 238 |
|
|
2015
Q3 | $85K | Hold |
21,200
| – | – | 0.01% | 208 |
|
|
2015
Q2 | $104K | Buy |
+21,200
| New | +$97.9K | 0.01% | 248 |
|
|
2015
Q1 | – | Sell |
-21,200
| Closed | -$83K | – | 272 |
|
|
2014
Q4 | $83K | Hold |
21,200
| – | – | 0.01% | 242 |
|
|
2014
Q3 | $79K | Hold |
21,200
| – | – | 0.01% | 240 |
|
|
2014
Q2 | $73K | Hold |
21,200
| – | – | 0.01% | 229 |
|
|
2014
Q1 | $73K | Hold |
21,200
| – | – | 0.01% | 224 |
|
|
2013
Q4 | $71K | Hold |
21,200
| – | – | 0.01% | 227 |
|
|
2013
Q3 | $77K | Hold |
21,200
| – | – | 0.01% | 228 |
|
|
2013
Q2 | $106K | Buy |
+21,200
| New | +$98.3K | 0.01% | 236 |
|
Other funds holding CEMI
VF
S
Phocas Financial Corp's CEMI Position: Q4 2022 in Review
Phocas Financial Corp sold out of Chembio diagnostics, Inc. (CEMI) in Q4 2022, closing a stake of 10,000 shares — an estimated $4K sold.
Phocas Financial Corp first reported a position in CEMI in Q2 2013 and held it in 35 quarters. The position peaked at $222K in Q2 2018. 38 funds tracked by Wall St. Rank hold CEMI as of Q4 2022.
- Phocas Financial Corp reported no remaining Chembio diagnostics, Inc. position as of Q4 2022 after selling out during the quarter.
- Phocas Financial Corp sold 10,000 Chembio diagnostics, Inc. shares in Q4 2022, an estimated $4K.
- Phocas Financial Corp first reported a position in Chembio diagnostics, Inc. in Q2 2013 and held it in 35 quarters.
- Phocas Financial Corp's Chembio diagnostics, Inc. position peaked at $222K in Q2 2018.
- 38 funds tracked by Wall St. Rank held Chembio diagnostics, Inc. as of Q4 2022.
Based on Phocas Financial Corp's 13F filing for Q4 2022, filed 11 Jan 2023.